I wanted to touch on the critical items. We've got the sort of principal team all kind of locked in the same conference room, working day and night to make sure that patients get what they need. Lutetium is essentially a smart bomb for cancer and for especially for late stage cancer patients. There's not really any other good solutions, but the supply chain is really pretty terrible for Lutetium.
The overall bottom line is this has resulted in shortages of this smart bomb. The solutions right there, but you can't access it. And that's not okay. So in our pilot plant, we have been since last year producing small quantities of the Lutetium to be available for research and trials. What the market needs is a lot of the Lutetium, so they need commercially viable volumes.
So we're going to walk into the war room and again, that's an area of high collaboration. We scale up our therapeutics, full scale launch. Like for example, these are manipulators. The environments in a hot cell environment. We need to use those to actually work on things inside the hot cells so they can quickly iterate here, make sure it'll work in a simulated environment, with real hardware, and then move it to the production environment.
So just allows things to go a lot faster. All right. So now we're officially entering the Cassiopeia clean room environment. So this facility is an advanced clean room environment designed for high quality standards to make sure we don't do any biological contamination. So this is sort of the engine of the building. There will actually be a couple lines set up in Cassi as we scale up.
So you can see here one of our unique pieces of capital. These are our hot cell banks and essentially the process, goes through from left to right, and really implements our, our proprietary front end technology, which lets us scale. Like I said, gives us a lot more flexibility over how we produce the Lutetium lets us scale better than our competition.
This line itself, should be capable of producing somewhere around 50 to 100,000 doses per year. there's another line, going in next door to this, and then there's the ability to build out an additional two lines within Cassi as we grow. So, it should be one of the biggest, if not the biggest Lutetium production facilities in the world.
And it's just really exciting to think of, like, how many lives are going to be saved, just by this building. We're really close, to turning it on. We are at the most exciting part of our commercial scale up project, which is actually installing equipment and moving into the building. We are wrapping up facility construction. We are installing, our major equipment, our hot cells that we use for safely processing and really like looking forward to completing our certifications and validations by the end of this year so that we can be in production of commercially viable quantities in 2024.
